Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01935440 · ClinicalTrials.gov registry record · NA
A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 632
- Enrollment target
NCT01935440: Completed NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT01935440 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 632 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01935440, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 632 participants
- Enrollment target
Study Summary
The goal of this study is to conduct an HIV prevention intervention to train HIV seropositive drug users to be peer health educators.
Interventions
- BEHAVIORAL Prevention & Testing
- BEHAVIORAL Prevention & Testing Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 632 participants |
| Start Date | 2012-11-01 |
| Est. Completion | 2017-01-31 |
| Phase | NA |
What the finished NCT01935440 record still lists
NCT01935440 is an interventional study that assigns participants to a tested intervention. The registered 632 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 2 interventions - of which Prevention & Testing is the first listed.
NCT01935440 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01935440 about?
NCT01935440 is a clinical study titled "A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives". The goal of this study is to conduct an HIV prevention intervention to train HIV seropositive drug users to be peer health educators.
What is the current status of trial NCT01935440?
This trial is currently completed. It is a NA study. The enrollment target is 632 participants. The study started on 2012-11-01. Estimated completion is 2017-01-31.
What interventions are being tested in trial NCT01935440?
The interventions under investigation include: Prevention & Testing (BEHAVIORAL), Prevention & Testing Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT01935440?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01935440's enrollment target sits among peer trials
632 159th of 2000 higher than 1,842 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05744973 · 631 participants
Multi-level Predictors of Structural Racism and Discrimination and Associations With Health and Well-being Across the Life Course in Diverse Families
- NCT00573027 · 634 participants · NA
Heart Disease of the Small Arteries in Women and Men
- NCT04108156 · 634 participants · Phase 3
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
- NCT07237295 · 634 participants · NA
CommunityRx-Kidney Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI